These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1350709)

  • 1. Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients.
    Jorkasky DK; Audet P; Shusterman N; Ilson B; Dafoe D; Hedrich D; Stote RM
    Am J Kidney Dis; 1992 Jun; 19(6):567-72. PubMed ID: 1350709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam.
    Brooks DP; Drutz DJ; Ruffolo RR
    J Pharmacol Exp Ther; 1990 Aug; 254(2):375-9. PubMed ID: 1974632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog.
    Nichols AJ; Koster PF; Brooks DP; Ruffolo RR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):269-74. PubMed ID: 1346161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
    Wang YX; Gellai M; Brooks DP
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenoldopam improves renal hemodynamics impaired by positive end-expiratory pressure.
    Poinsot O; Romand JA; Favre H; Suter PM
    Anesthesiology; 1993 Oct; 79(4):680-4. PubMed ID: 8105727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion.
    Ruggenenti P; Perico N; Mosconi L; Gaspari F; Benigni A; Amuchastegui CS; Bruzzi I; Remuzzi G
    Kidney Int; 1993 Mar; 43(3):706-11. PubMed ID: 8455370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
    Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of renal blood flow during hypotension induced with fenoldopam in dogs.
    Aronson S; Goldberg LI; Roth S; Glock D; Moss J; Roizen MF
    Can J Anaesth; 1990 Apr; 37(3):380-4. PubMed ID: 1969772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of the prostaglandin E1 analogue, enisoprost, to reverse chronic cyclosporine-associated renal dysfunction.
    Pollak R; Knight R; Mozes MF; Maddux M; Veremis S; Van Buren C; Lewis R; Scott E; Cole M; Hyndman V
    Am J Kidney Dis; 1992 Oct; 20(4):336-41. PubMed ID: 1415200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation.
    Pollock DM; Arendshorst WJ
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F627-35. PubMed ID: 1969238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dopamine DA-1 receptor agonist fenoldopam enhances amino-acid-induced hyperemia in dogs.
    Brooks DP; DePalma D
    Pharmacology; 1993 Jul; 47(1):43-9. PubMed ID: 8101655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and endocrine effects of fenoldopam and metoclopramide in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Nephron; 1990; 56(2):179-85. PubMed ID: 1978736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dopamine prodrugs and fenoldopam on glomerular hyperfiltration in streptozotocin-induced diabetes in rats.
    Barthelmebs M; Vailly B; Grima M; Velly J; Stephan D; Froehly S; Imbs JL
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):243-53. PubMed ID: 1717786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans.
    Ragsdale NV; Lynd M; Chevalier RL; Felder RA; Peach MJ; Carey RM
    Hypertension; 1990 Jun; 15(6 Pt 2):914-21. PubMed ID: 1972140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
    Shusterman NH; Elliott WJ; White WB
    Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.
    Harvey JN; Worth DP; Brown J; Lee MR
    Br J Clin Pharmacol; 1985 Jan; 19(1):21-7. PubMed ID: 2858215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
    Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ; Apparsundaram S; Lokhandwala MF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.